STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3861 by analyst upside · 2026-08-13
NTRA
Natera, Inc.
Healthcare · Market Cap $46B · P/E 0x
ANALYST PRICE TARGET
+0.3%
implied upside to consensus target
Current Price $315.96
Consensus Target $316.95
Bull Target $375.0
Bear Target $193.0
Analysts Covering 20
ANALYST CONSENSUS - BUY
Strong Buy
5
Buy
12
Hold
3
Sell
0
52-Week Low $152.62
52-Week High $326.03
YTD Return +38.1%
FUNDAMENTALS
Market Cap $46B
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-1.34
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $2.7B
Profit Margin -7.1%
52-WEEK RANGE
52-Week Low $152.62
52-Week High $326.03
Current Price $315.96
Bear Target $193.0
Bull Target $375.0
● Now $315.96 ● Target $316.95
TRADING DATA
Avg Volume 1.5M
YTD Return +38.1%
Analyst Count 20
Consensus Buy
Upside to Target +0.3%
Last Updated 2026-08-13

ANALYST SUMMARY

Natera, Inc. (NTRA) is currently trading at $315.96 with a Wall Street consensus price target of $316.95, implying potential upside of 0.3% over the next 12 months. 20 analysts currently cover NTRA, with a consensus rating of Buy - 85% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $375.0, while the most cautious has a target of $193.0.

NTRA operates in the Healthcare sector with a market capitalisation of $46B. The stock is up 38.1% year-to-date and is currently trading near the upper end of its 52-week range of $152.62 – $326.03.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for NTRA, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Goldman Sachs ● Initiated
Buy → Neutral 2026-06-05 Building track record
BTIG - Reiterated
Buy → Buy 2026-05-11 38% win rate (8 calls)
JP Morgan - Reiterated
Overweight → Overweight 2026-05-08 43% win rate (7 calls)
Evercore ISI Group - Reiterated
Outperform → Outperform 2026-05-08 Building track record
Wells Fargo - Reiterated
Equal-Weight → Equal-Weight 2026-05-08 Building track record
William Blair ● Initiated
Outperform 2026-04-14 44% win rate (9 calls)
Morgan Stanley - Reiterated
Overweight → Overweight 2026-03-03 Building track record
Wells Fargo - Reiterated
Equal-Weight → Equal-Weight 2026-02-27 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
63
out of 100
Coverage depth
23/30
Consensus clarity
18/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →